Epidemiological Study of Pediatric Neuromuscular Disorders in South West France Regions - Inserm - Institut national de la santé et de la recherche médicale Access content directly
Journal Articles (Review Article) Anaesthesia Critical Care & Pain Medicine Year : 2024

Epidemiological Study of Pediatric Neuromuscular Disorders in South West France Regions

Abstract

Norepinephrine is the first-line vasopressor used in acute cardio-circulatory failure. At the bedside, its dose is critical as it serves to determine the severity of patients, to compare the patients between different studies, and to start specific interventions. Recently, several investigators underlined differences in the expression of norepinephrine doses according to countries and manufacturers. For various reasons, all norepinephrine products are processed to a salt formulation thereby generating a stable and soluble conjugated acid in a slightly acidic solution. Depending on the salt used, the total weight will differ, but the weight of pure norepinephrine base is the same. This results in at-risk situations with large variations in terms of practices, evaluation and treatment. In this technical note, we summarized the evidence and provided a few suggestions to improve the practices at different levels.
Fichier principal
Vignette du fichier
2024 Goyer et al., Norepinephrine dosing in France.pdf (538.23 Ko) Télécharger le fichier
Origin Files produced by the author(s)

Dates and versions

hal-04597251 , version 1 (12-08-2024)

Identifiers

Cite

Isabelle Goyer, Ines Lakbar, Yonathan Freund, Bruno Lévy, Marc Leone. Epidemiological Study of Pediatric Neuromuscular Disorders in South West France Regions. Anaesthesia Critical Care & Pain Medicine, 2024, 43 (4), pp.101397. ⟨10.1016/j.accpm.2024.101397⟩. ⟨hal-04597251⟩
59 View
0 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More